Sionna Therapeutics Inc (SION) is trading down at $3.80 (-1.81%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
| FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|
| Income statement | ||
| Operating income | −$70.6M | −$89.0M |
| Net income | −$61.7M | −$75.3M |
| EPS (diluted) | −$15.99 | −$1.88 |
| Balance sheet | ||
| Cash and equivalents | $37.8M | $58.5M |
| Total assets | $185.8M | $326.0M |
| Total liabilities | $19.1M | $19.1M |
| Shareholders' equity | −$163.7M | $306.8M |
| Cash flow | ||
| Operating cash flow | −$52.8M | −$66.3M |
| Capital expenditure | $27.0K | $377.0K |
| Free cash flow | −$52.8M | −$66.7M |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | −$28.0M | −$18.1M | −$19.7M | −$21.9M | −$23.8M | −$23.6M | −$29.6M | −$32.5M |
| Net income | −$25.4M | −$15.8M | −$16.5M | −$18.1M | −$20.3M | −$20.4M | −$26.8M | −$29.9M |
| EPS (diluted) | −$5.67 | $6539.68 | −$0.62 | −$0.41 | −$0.46 | −$0.39 | −$0.60 | −$0.66 |
| Balance sheet | ||||||||
| Cash and equivalents | $35.7M | $37.8M | $82.7M | $41.0M | $50.8M | $58.5M | $63.3M | $63.3M |
| Total assets | — | $185.8M | $369.7M | $352.0M | $339.3M | $326.0M | $305.0M | $283.2M |
| Total liabilities | — | $19.1M | $17.9M | $15.6M | $17.6M | $19.1M | $16.8M | $17.5M |
| Shareholders' equity | −$148.5M | −$163.7M | $351.8M | $336.4M | $321.7M | $306.8M | $288.2M | $265.8M |
| Cash flow | ||||||||
| Operating cash flow | −$17.7M | −$11.8M | −$16.3M | −$18.2M | −$15.2M | −$16.6M | −$21.8M | −$22.2M |
| Capital expenditure | $0 | $27.0K | $86.0K | $0 | $87.0K | $204.0K | $0 | $0 |
| Free cash flow | −$17.7M | −$11.8M | −$16.4M | −$18.2M | −$15.3M | −$16.8M | −$21.8M | −$22.2M |
From Sionna Therapeutics Inc's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
No recent news mentioning Sionna Therapeutics Inc in our feed yet.